IGF1 and breast cancer: There are fewer data on biomarkers for women at elevated breast cancer risk; these results suggest that elevated levels of IGF-1 and IGFBP-3 may be similarly related to breast cancer risk on a relative scale irrespective of absolute baseline risk.